MLSC Convenes Expert Panel on the Future of Imaging and Data Science |
|
Last week, the MLSC convened stakeholders at the Beyond Bits to Bytes event at the Broad Insititute. The focus of the well-attended program was how data is rapidly changing patient care. The gathering featured expert perspectives from industry and academic research partners leading in this space.
The role of data science in life science innovation is rapidly growing and evolving. The information explosion, combined with emerging algorithms, has the potential to reduce the drug discovery timeline, improve patient experience, and provide clinicians with better diagnostic tools. During this time of digital transformation, the potential exists to derive value from a wide variety of data sources, including next-generation sequencing, mass spectrometry, electronic health records, images, and consumer wearables.
The MLSC recently launched the second round of its Bits to Bytes Capital Call, deadline January 23, 2020, to provide funding for projects that will generate and analyze large datasets to answer pressing life science questions, and train data scientists in the Commonwealth. The inaugural round of Bits to Bytes provided $6.7 million in capital funding to nine data-driven, cross-sector projects focused on imaging, cancer, neuroscience, drug discovery, and clinical trial design. The MLSC also recently launched its Advanced Analytics/Data Science Internship Program, focused on enhancing the availability of advanced analytics/data science talent in life sciences.
Read the full article: ‘Data is King’: Massachusetts Life Sciences Center convenes gathering on future of imaging and data science |
|
Curbed Boston: The Boston area’s booming life sciences industry and why it matters for real estate Key Sentence: That’s because the Boston area has become the national capital of the life sciences industry. A February 2019 report from commercial brokerage CBRE put the region at or near the top of just about every measure of the industry’s health.
Forbes: A Pharma Startup Launches With $200 Million In Funding And A Strategy To Make Drugs Faster, Cheaper Key Sentence: Their startup EQRX came out of stealth on Sunday with $200 million in funding from Andreessen Horowitz, ARCH Venture Partners and GV, and an ambitious goal to develop ten new medications in the next ten years. They plan to do this by focusing exclusively on known biological targets and relying heavily on technology.
WBJ: Plans advancing for Worcester's Reactory site Key Sentence: WuXi would be a major boon for the project and for Worcester, with the site becoming the company's first American biomanufacturing facility. The 110,000 square-foot facility would employ 150 workers and be tentatively built next to pharmaceutical firm AbbVie on Belmont Street.
FiercePharma: Blueprint wins first FDA nod for a stomach cancer—though not exactly what it asked for Key Sentence: The FDA on Thursday greenlighted Blueprint’s Ayvakit, also known as avapritinib, for patients with rare gastrointestinal stromal tumor (GIST) carrying a platelet-derived growth factor receptor alpha (PDGFRα) exon 18 mutation. It's the drug's first step toward building a blockbuster-worthy list of targeted FDA approvals |
|
Follow the MLSC on social media for the latest events, news, and information.
|
|
How The MassBio Community Can Accelerate Positive Transportation Solutions For MA When: January 28, 2020, 8:00 am - 10:00 am Where: MassBio, 300 Technology Square, 8th Fl, Cambridge This MassBio forum will provide members with a better, more critical understanding of the state of transit in Massachusetts. Our panel, representing local and national associations, advocacy groups, and public agencies will highlight a transportation vision for MA, the current state of transit including challenges and opportunities, and positive solutions proposed or in the works.
Venture Funding Happy Hour at M2D2! When: February 24, 2020, 5:00 pm - 8:30 pm Where: M2D2, 110 Canal Street, 4th Fl, Lowell Startups: If you’re committed to your business vision, then you MUST start planning for venture financing.
2020 M2D2 $200K Challenge Pitch-Off When: March 25, 2020, 5:00 pm - 9:00 pm Where: University Crossing, 220 Pawtucket St, Lowell Join the New England life sciences community as a global field of medical device and biotech innovators pitch their ideas to our investor panel for a share of a $200,000!
Driving Health Care Strategy: Insights from Inside the Ecosystem When: April 28, 2020 - April 30, 2020 Where: Harvard Medical School, 25 Shattuck St., Boston This Harvard Medical School Executive Education program is an intensive experience where participants learn from leading HMS faculty experts while networking with a cohort of professional peers.
To check out upcoming life sciences events happening throughout our ecosystem, click here. Submit your event here. |
|
|
After Four Years of Successful Leadership, McCready Steps Down |
|
Travis McCready, after more than four years of successful leadership of the Massachusetts Life Sciences Center, stepped down from his role as President and CEO, January 8, 2020.
Mr. McCready oversaw a period of tremendous growth and output during his tenure at the Life Sciences Center. Through a collaborative strategy with regionalization and equity at its core, the MLSC and its partners were able to steward a period of immense success in expanding life sciences growth outside of Boston and Cambridge. We thank him for his contributions and wish him well in his future endeavors.
Timothy J. McGourthy, Deputy Secretary at Executive Office of Housing and Economic Development will assume the interim role of Acting President and CEO of the MLSC.
Read the full press release: Baker-Polito Administration Announces Leadership Transition at Massachusetts Life Sciences Center |
|
2020 Internship Programs Now Open |
|
The MLSC is excited to announce that applications are now open for the 2020 Internship Challenge, High School Apprenticeship Challenge, and the Advanced Analytics/Data Science Internship Program. Our internship programs exemplify the MLSC's commitment to ensuring that students are prepared for career success in this vibrant industry and to build a talent pipeline that meets the industry’s growing need for a well-prepared workforce. 
The Internship Challenge creates over 550 new internship opportunities each year for college students interested in pursuing careers in the industry. The program connects Massachusetts companies with students and provides funding that enables small companies, with 100 or fewer employees, to hire paid interns for up to 12 weeks. Undergraduates and Master’s students studying or living in the state are eligible to apply. Apply today>>
The High School Apprenticeship Challenge creates over 150 summer internship opportunities for high school students interested in STEM. Students are eligible to apply for six-week paid internships with research institutions and life sciences companies. Students must be Massachusetts high school students and 16 years or older to qualify. Apply today >>
The new Advanced Analytics/Data Science Internship Program focuses on enhancing the availability of advanced analytics/data science talent in life sciences. In this pilot year, the program will create internship opportunities for qualified candidates at the Bachelor’s, Master’s, and Doctoral levels by enabling research institutions and companies to hire paid interns for up to six months. Apply today >> |
|
BioSpace: Top Life Sciences Startups to Watch in 2020 Key Sentence: To come up with this list, BioSpace sorted companies into that age grouping, and they were then weighted by a number of different categories and finally ranked in a cumulative fashion, based on the points awarded for each category. These categories were: Finance, Collaborations, Pipeline, and Innovation.
FierceBiotech: Allurion nets $34M to market its swallowable weight-loss balloon Key Quote: “Allurion’s cutting-edge approach to one of the world’s largest unmet medical needs has the company poised for long-term success,” said Marijn Dekkers, founder and chairman of Novalis LifeSciences and former CEO of Bayer and Thermo Fisher Scientific. “I believe that the company’s rapid growth is further evidence that its weight loss program has an attractive value proposition for both consumers and physicians.”
Boston Globe: A worker shortage for life sciences Key Sentence: According to a report released last month by the Massachusetts Biotechnology Education Foundation, there has been a 35 percent increase in life sciences jobs in the state over the past decade. |
|
Follow the MLSC on social media for the latest events, news, and information.
|
|
MLSC Tax Incentive Web Info Session When: January 15, 2020, 10:00 am - 11:30 am Where: Webinar The info session will provide an overview of the Tax Incentive Program, including eligibility requirements, various tax incentives available, explanation of the application process, and the timeline for awards.
Life Science Cares Partner Pitch Event When: January 22, 2020, 5:30 pm - 7:30 pm Where: CIC Cambridge, One Broadway, Cambridge, MA Learn about local nonprofits in a low-pressure environment and network with peers.
How The MassBio Community Can Accelerate Positive Transportation Solutions For MA When: January 28, 2020, 8:00 am - 10:00 am Where: MassBio, 300 Technology Square 8th Fl, Cambridge, MA This MassBio forum will provide members with a better, more critical understanding of the state of transit in Massachusetts. Our panel, representing local and national associations, advocacy groups, and public agencies will highlight a transportation vision for MA, the current state of transit including challenges and opportunities, and positive solutions proposed or in the works.
Venture Funding Happy Hour at M2D2! When: February 24, 2020, 5:00 pm - 8:30 pm Where: M2D2, 110 Canal Street, 4th Floor, Lowell, MA Startups: If you’re committed to your business vision, then you MUST start planning for venture financing.
To check out upcoming life sciences events happening throughout our ecosystem, click here. Submit your event here. |
|
BBJ: One particular field of drug development could dominate M&A in 2020 Key Sentence: Massachusetts life science companies were involved in $34 billion worth of M&A deals this year. But experts say next year will be even busier.
ENDPOINT NEWS: Allergan gets a win: FDA approves ubrogepant as cascade of treatments reshape migraine field Key Sentence: The drug, branded Ubrelvy, is the latest in a series of migraine drug approvals that have begun to reshape an often debilitating ailment the FDA estimates affects 37 million Americans.
STAT: 3 stories to watch in health tech in 2020 Key Sentence: Judging by the numbers, digital health companies had another huge year in 2019. Total investment in the sector was expected to reach a record $8.4 billion, as firms raked in cash to develop novel wearables, personalized digital services, and machine learning tools to improve treatment of debilitating diseases. |
|
Follow the MLSC on social media for the latest events, news, and information.
|
|
Post-Seed Venture Capital: What Is It? Is it Right for Me? When: January 8, 2020, 5:30 pm - 8:00 pm Where: M2D2, 110 Canal Street, 4th Floor, Lowell Even if your startup is brand-new, NOW is the time to map out your complete business growth path — all the way to venture financing.
MLSC Tax Incentive Info Session When: January 10, 2020, 10:00 am - 11:30 am Where: MLSC Office, 1075 Main Street, Suite 100, Waltham In order to expand life sciences-related employment opportunities, promote health-related innovations and stimulate research and development, manufacturing and commercialization in the life sciences, the Massachusetts Life Sciences Center is pleased to announce that it is offering tax incentives to companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. The primary goal of the program is to incentivize life sciences companies to create new long-term jobs in Massachusetts.
Beyond Bits to Bytes: Looking to the Future in Imaging and Data Science When: January 13, 2020, 3:00 pm - 5:00 pm Where: Broad Institute, 415 Main Street, Cambridge The role of data science in life science innovation is rapidly growing and evolving. If harnessed, the information explosion has the potential to catalyze new discoveries and treatments in healthcare to benefit patients in need. During this time of digital transformation, the potential exists to derive value from a wide variety of data sources, including next generation sequencing, mass spectrometry, electronic health records, images, and consumer wearables.
Recombinant Antibody and Biosimilars course When: January 15, 2020 - January 17, 2020, 8:30 am - 12:00 pm Where: Northeastern University, Innovation Campus at Burlington, 147 S. Bedford Street, Burlington Northeastern’s BATL offers Recombinant Antibody and Biosimilars course, with lectures and hands-on training.
MLSC Tax Incentive Web Info Session When: January 15, 2020, 10:00 am - 11:30 am Where: Webinar In order to expand life sciences-related employment opportunities, promote health-related innovations and stimulate research and development, manufacturing and commercialization in the life sciences, the Massachusetts Life Sciences Center is pleased to announce that it is offering tax incentives to companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. The primary goal of the program is to incentivize life sciences companies to create new long-term jobs in Massachusetts.
To check out upcoming life sciences events happening throughout our ecosystem, click here. Submit your event here. |
|
|
|
沒有留言:
發佈留言